Progression of human colon cancer is often associated with elevated expression and activity of the Src family tyrosine kinase (SFK). SFK is ordinarily in equilibrium between inactive and primed states by a balance of negative regulatory kinase Csk and its counteracting tyrosine phosphatase(s), both of which act on the regulatory C-terminal tyrosine of SFK. To evaluate the contribution of the regulatory system of SFK in cancer progression, we here modulated the equilibrium status of SFK by introducing wild-type or dominant-negative Csk in human epithelial colon cancer cells, HCT15 and HT29. Overexpression of wild-type Csk induced decreased SFK activation, increased cell-cell contacts mediated by E-cadherin, decreased the number of focal contacts and decreased cell adhesion/migration and in vitro invasiveness. Conversely, expression of a dominant-negative Csk resulted in elevated SFK activation, enhanced phosphorylation of FAK and paxilllin, enhanced cell scattering, an increased number of focal contacts, dramatic rearrangement of actin cytoskeleton and increased cell adhesion/ migration and in vitro invasiveness. In these scattered cells, however, localization, expression and phosphorylation of either E-cadherin or b-catenin were not significantly affected, suggesting that the E-cadherin-mediated cell-cell contact is indirectly regulated by SFK. Furthermore, all these events occurred absolutely dependent on integrin-mediated cell adhesion. These findings demonstrate that Csk defines the ability of integrin-SFKmediated cell adhesion signaling that influences the metastatic potential of cancer cells.
Introduction
The Src family tyrosine kinase (SFK) has been shown to play an important role in proliferation, differentiation, adhesion and migration of a variety of animal cells.
These diverse functions are due to the pivotal role of SFK as membrane-attached molecular switches that link a variety of extracellular cues to crucial intracellular signaling pathways (Thomas and Brugge, 1997) . The kinase activity of c-Src is known to be highly elevated in the majority of human colon cancers, and there is an increasing trend during further disease progression, with the highest values in metastasis disease (Talamonti et al., 1993) . In addition, some types of adenomas and ulcerative colitis, which possess a high risk of developing malignant disease, also course with increased c-Src activity (Cartwright et al., 1994) . This increased c-Src activity does not appear to result solely from an increase in the amount of the c-Src protein, suggesting that its specific activity is enhanced in some cases Cartwright et al., 1989) . A subset of colon cancers has a nonsense mutation in the C-terminal regulatory domain of c-Src. This mutation has been demonstrated to be activating, tumorigenic and to promote metastasis (Irby et al., 1999) . However, since the frequency of this mutation appears to be very low, it seems unlikely to play a significant role in the progression of most colon cancers (Daigo et al., 1999; Nilbert and Fernebro, 2000; Wang et al., 2000; Laghi et al., 2001) . On the other hand, some cases of colon cancer have shown an upregulation of other members of SFK, such as Yes and Lck, suggesting that SFK upregulation in cancer cells might be a more common event Boardman and Karnes, 1995) .
The C-terminal Src kinase (Csk) is a cytoplasmic tyrosine kinase that serves as an essential and a common negative regulator of SFK through specific phosphorylation at the C-terminal regulatory site of SFK (Tyr-529 in human c-Src) (Okada and Nakagawa, 1989; Nada et al., 1991) . The phosphorylated C-terminal tyrosine binds intramolecularly to the SH2 domain of SFK, thereby generating an inactive conformation Sabe et al., 1992a) . The importance of Csk as a negative regulator for SFK and the absence of functional redundancy have been demonstrated by the observation that Csk knockout mice, which are lethal at prenatal stage, exhibited constitutive activation of multiple SFK members (Imamoto and Soriano, 1993; Nada et al., 1993) . It is now believed that the activity of SFK is determined by an equilibrium between an inactive (phosphorylated) and a primed (dephosphorylated) state regulated by a balance of Csk and its counteracting tyrosine phosphatase(s). Upon cell stimulation, SFKs at a primed state become functionally activated to relay signals into the cells. Thus, perturbation of the equilibrium status of SFK, potentially induced by up-or downregulation of Csk and/or a tyrosine phosphatase(s) during development and/or cancer progression, may greatly affect the sensitivity of the cells to extracellular cues. In relation to cancer progression, it has been reported that c-Srcinduced transformation of cells bearing v-Crk was suppressed by Csk overexpression (Sabe et al., 1992b) . In addition, downregulation of Src kinase activity by adenovirus-mediated csk gene transfer has been shown to abrogate the metastatic phenotype of colon cancer cells (Nakagawa et al., 2000) . We previously reported a reduction of Csk protein in about 60% of human colon cancer cases in which there was an elevation of Src activity, indicating that reduction of Csk may be one of the causes of the elevated specific activity of c-Src (Rengifo-Cam et al., 2001) . These findings suggest that Csk could be involved in the regulation of some cancer progression, through controlling the activity status of multiple SFKs. However, the precise function of Csk in human colon cancer cells has not been yet established. To address this issue, we examined the effects of modulation of Csk function on the phenotypes of human colon cancer cells. We here show that the equilibrium status of SFK controlled by Csk could control the integrin-mediated cell adhesion and migration implicated in the metastatic potential of human colon cancer cells.
Results and discussion
Expression and activity of SFK in human epithelial colon cancer cells
We first analysed protein expressions of Csk and SFK and the activity status of SFK in human colon cancer cell lines (Dan et al., 2002), HCC2998, HCT15 and HT29 (Figure 1a) . Consistent with previous observations (Rosen et al., 1986; Rengifo-Cam et al., 2001) , HCT15 and HT29 cells showed substantial elevation of c-Src expression and a reduced expression of Csk compared with HCC2998 cells, a highly differentiated adenocarcinoma cell line (Kobayashi et al., 1999) . It was also shown that all these cells express multiple members of SFK including Yes, Fyn, Lyn and Lck, although there were no dramatic changes in their expressions among them. The activity status of SFK was then assessed with anti-Src pY418 antibody that can recognize autophosphorylated tyrosines of SFKs (SFK pY418), since SFK autophosphorylation is directly associated with its function (Sabe et al., 1992a, b) . HCC2998 cells demonstrated only faint signals for SFK autophosphorylation, while HCT15 and HT29 cells showed substantial phosphorylation on SFKs potentially corresponding to c-Src and c-Yes. In contrast, phosphorylations at the negative regulatory sites, Y529, were steadily detected in all cell types with the highest levels in HT29 cells. To verify the phosphorylation levels of individual SFK members, c-Src and c-Yes proteins were immunoprecipitated and subjected to Western blotting ( Figure 1b) . In HT29 cells, c-Src was substantially phosphorylated at both Y418 and Y529, revealing that some c-Src are at primed state, while others are downregulated by Csk. In the case of c-Yes, phosphorylation at Y418 was the most evident in HT29 cells, while Y529 appeared to be less phosphorylated in the same cell line. These observations demonstrate that not only c-Src but also some other SFKs including c-Yes are basally primed in advanced cancer cells such as HT29, but only slightly activated in highly differentiated HCC2998 cells. This raises the possibility that perturbation of the balance between SFK and Csk, potentially achieved by elevated expression of SFK, downregulation of Csk or both, might influence the activity status of SFK in cancer cells. In order to address the role of such regulatory system of SFK in cancer progression, we here modulated the SFK-Csk balance by introducing Csk into HCT15 and HT29 cells, and observed its effects on the activity status of SFK and the phenotypic features of cancer cells.
Modulation of SFK by Csk influences cell morphology, cell-cell interaction, cell motility and in vitro invasiveness in colon cancer cells
We introduced wild-type Csk (Csk K þ ) or kinasenegative mutant of Csk (Csk KÀ) in HCT15 and HT29 (C and H) . When the aggregated HCT15 cells expressing Csk K þ were subsequently infected with virus carrying Csk KÀ, the cells became scattered again, demonstrating that the morphological changes can be regulated reversibly (D). As reported previously (Nam et al., 2002) , treatment with PP2, a specific inhibitor of SFK, induces cell aggregation in both cell types (E and J). Cell aggregation could also be induced by the PP2 treatment in HT29 cells expressing Csk KÀ (I). The morphology of PP2-treated cells is somewhat similar to that of Csk K þ cells, supporting the idea that morphological changes induced by Csk expression are mediated by the modulation of SFK activity.
To further characterize Csk-expressing cancer cells, the infected HT29 cells were replated onto collagencoated dishes and their behaviors were observed for 21 h under time-laps video microscopy. The images at 3 h intervals and the tracks of five cells in each cell type are shown in Figure 2c . Overexpression of Csk K þ appeared to attenuate cell motility, and also the cells tended to associate with each other resulting in the formation of compact cell aggregates. In contrast, the Csk KÀ cells actively migrated without forming the cell aggregates. We then assessed the in vitro invasive potential of the infected HCT15 and HT29 cells by matrigel assay (Figure 2d ). The Csk KÀ cells efficiently invaded matrigel, whereas the invasiveness of Csk K þ cells was rather suppressed. This supports the previous observation showing that adenovirus-mediated csk gene transfer can abrogate the metastatic phenotype of colon cancer cells in vivo (Nakagawa et al., 2000) . Taken together, these observations suggest that the activity status of SFK regulated by Csk might influence the ability of cell migration implicated in the metastatic potential of human colon cancer (Avizienyte et al., 2002) .
Modulation of SFK by Csk influences integrin-SFK-mediated cell adhesion signaling
We then addressed the molecular mechanisms that determine the phenotypes of the infected HT29 cells. When cells were plated onto culture dishes coated with collagen I, evident changes in morphology were observed again; overexpression of Csk K þ induced formation of large cell aggregates, while that of Csk KÀ facilitated the cell scattering and destabilized cell-cell contacts (Figure 3aA-C) . However, when cells were plated onto laminin-coated dishes, the morphological change became more moderate and large cell aggregates were stably formed even in Csk KÀ cells (Figure 3aD-F) . These findings suggest that the effects of Csk are dependent on cell adhesion mediated by specific integrins that can respond to collagen I. To confirm this, cell adhesion assay on collagen I was performed. As shown in Figure 3b , cell adhesion was apparently suppressed by the expression of Csk K þ , while it was greatly enhanced by that of Csk KÀ. The changes in tyrosine phosphorylation of cellular proteins during cell adhesion process were then examined by Western blotting (Figure 3c) . In suspended cells, SFK is phosphorylated dominantly at Y529 in Csk K þ cells, while in Csk KÀ cells, it is phosphorylated at Y418. This can be attributed to a change in the equilibrium of SFK to an inactive state in Csk K þ cells and to a primed state in Csk KÀ cells. Upon cell adhesion, the primed SFK in Csk KÀ cells became functionally activated resulting in a dramatic increase in tyrosine phosphorylation of several SFK targets including FAK and paxillin, which play crucial roles in the formation of focal contacts. Phosphorylation of FAK Y397 was also induced, reflecting the activation of FAK implicated in the regulation of cell migration and invasion (Hauck et al., 2002) . In contrast, inactive state of SFK in Csk K þ cells cannot be activated through integrin signaling, and consequently there is no significant increase in the phosphorylation of cell adhesion-related proteins. The importance of cell adhesion mediated by specific integrin was further supported by the observation that tyrosine phosphorylation of cell adhesion proteins was not induced even in Csk KÀ cells when plated onto laminin or poly-d-lysine-coated dishes (data not shown). These results show that Csk is critical to define the sensitivity of the cells to the integrin-SFK-mediated cell adhesion signaling.
Modulation of SFK by Csk influences focal contact formation and actin cytoskeletal organization
We next investigated the cellular localizations of tyrosine phosphorylated proteins (pY), vinculin, as markers of focal contact, and actin fiber (F-actin) by confocal microscopy (Figure 4a ). Csk K þ cells showed reduced numbers of staining patches of pY and vinculin that were localized only at the edge of large cell aggregates, suggesting that focal contacts are formed at places that can directly interact with the substrate (Figure 4a and c, B) . Consistent with this, staining of F-actin was evident only at the edge of cell aggregates as well (Figure 4a and c, E) . In contrast, in Csk KÀ cells, the number of focal contacts was greatly increased, and they appeared surrounding the individual cells (Figure 4a and c, C). F-actin was also enriched around the focal contacts of each cell (Figure 4a and c, F) . At the middle surface of Csk K þ cells, F-actin appeared highly concentrated at cell-cell contacts probably for the support of E-cadherin/b-catenin complex (Figure b, E) , whereas in Csk KÀ cells, such actin support was substantially reduced (Figure b, F) . These observations indicate that expression of Csk K þ suppresses the formation of focal contacts while that of Csk KÀ enhances it through the increased phosphorylation of cell adhesion machinery, and that there is a drastic rearrangement of actin cytoskeletal organization accompanied by the formation of focal contacts.
Modulation of SFK by Csk does not affect the E-cadherin/b-catenin complex
We here addressed the mechanism by which cell-cell contact is stabilized in Csk K þ cells, while it is destabilized in Csk KÀ cells. It is known that E-cadherin plays a major role in cell-cell contact of epithelial cells (Hyafil et al., 1980) . Indeed, an anti-E-cadherin antibody could completely inhibit the formation of compact cell aggregates in Csk K þ cells (Figure 5a ), suggesting that SFK activity under the control of Csk is involved in the regulation of E-cadherin-mediated cell-cell contacts. Previous reports have suggested a role for activated form of Src in dissociating the E-cadherin/b-catenin complex (Irby and Yeatman, 2002) . Thus, we investigated the localization of E-cadherin and its partner b-catenin in HT29 cells expressing Csk K þ or Csk KÀ. However, there was no apparent difference in the staining patterns of either E-cadherin or b-catenin in any type of cells (Figure 5b) . Both E-cadherin and b-catenin were predominantly localized at the membrane (Aberle et al., 1997) or endocytosis of the E-cadherin/b-catenin complex (Fujita et al., 2002) . To test the possible effect of up-or downregulation of Csk on this mechanism, we determined the protein amounts of the E-cadherin/b-catenin complex and other potential Src targets, a-catenin and p120 CTN , and the tyrosine phosphorylation of E-cadherin/ b-catenin complex. As shown in Figure 5c , there was no significant change in the amounts of any protein tested in either Csk K þ or Csk KÀ cells. In addition, only a subtle increase in tyrosine phosphorylation of either Ecadherin or b-catenin was detected even in Csk KÀ cells. These findings demonstrate that there is no apparent change in E-cadherin/b-catenin related cell-cell contact machinery and that the activity of endogenous SFK is not sufficient for the phosphorylation-mediated endocytosis of the E-cadherin/b-catenin complex. This raises the possibility that cell-cell contact mediated by E-cadherin/b-catenin is deregulated by SFK through an indirect pathway. Supporting this possibility, we observed that there was a dramatic mobilization of F-actin from cell-cell contacts to focal contacts by modulating SFK function (Figure 4a ). Thus, it seems likely that rearrangement of actin cytoskeleton induced by SFK activation causes a loss of actin-support for the E-cadherin/b-catenin complex, thereby destabilizing clustering of the complex that allows high-affinity interaction.
Csk could control metastatic potential of cancer cells through regulating integrin-SFK-mediated cell adhesion signaling
In summary, we here showed that upregulation of Csk in human epithelial cancer cells suppresses the activation of SFK upon cell adhesion, thereby allowing cell-cell contacts mediated by E-cadherin leading to epitheliallike phenotype, and conversely that downregulation of Csk greatly enhances integrin-mediated activation of SFK, which accompanies increased phosphorylation of cell adhesion proteins, cell scattering with mesenchymallike phenotype, increased number of focal contacts, reorganization of cytoskeletal support, enhanced cell adhesion and migration and in vitro invasiveness. These observations suggest that Csk plays a key role in the regulation of the activity status of SFK that influences epithelial-mesenchymal transition (EMT) and the metastatic potential of epithelial cancer cells. Src has been implicated in the regulation of EMT (Frame, 2002) , and Figure 4 Effect of Csk overexpression on the formation of focal contacts and arrangements of actin cytoskeleton. HT 29 cells were infected with adenovirus as described above, and stained with 4G10 (a and b) or anti-vinculin antibody (c) followed by detection with FITC-conjugated anti-mouse IgG. F-actin was stained by rhodaminephalloidine. Immunofluorescence confocal microscopy pictures were taken at the cell basement in contact with the substratum (basal surface) or 2 mm above the basal surface (middle surface) requirement of integrin signaling in such process has also been reported (Avizienyte et al., 2002) . However, most of the studies on the function of Src were performed using v-Src or active form of Src having a mutation at the C-terminal regulatory site. A natural Src mutant, Src531 (Irby et al., 1999) , has also been used, but this mutation does not seem to occur frequently (Daigo et al., 1999; Nilbert and Fernebro, 2000; Wang et al., 2000; Laghi et al., 2001) . These molecules cannot be regulated by Csk and show constitutively high activity. Using these activated forms of Src, it has been proposed that deregulation of cell-cell contacts mediated by E-cadherin is due to SFK-induced phosphorylation of E-cadherin/b-catenin complex leading to endocytosis and degradation of the complex (Aberle et al., 1997; Fujita et al., 2002) . In the present study, however, significant phosphorylation and degradation of E-cadherin/b-catenin complex were not observed, suggesting that endogenous SFK activity is not sufficient or too weak to be responsible for such degradation pathway of E-cadherin/b-catenin complex in some cancer cells. Nonetheless, the E-cadherin-mediated cell-cell contacts were destabilized by the activation of SFK. In this study, we proposed the possibility that endogenous SFK dominantly regulates integrinmediated cell adhesion in any cell type. Thus, it would be possible that deregulation of cell-cell contacts may result from secondary events such as reorganization of actin cytoskeleton, although more detailed analysis for the molecular mechanism underlying these events should be necessary. As already mentioned, other members of SFK, Yes and Lck, are upregulated in some colon cancers Boardman and Karnes, 1995) . In HCT15 and HT29 cells used in this study, a variety of SFK members, that is, Src, Yes, Fyn, Lyn and Lck, are expressed and some are indeed activated. In addition, multiple members of SFK, including Src, Fyn, Hck and Fgr, have been shown to be involved in integrin signaling that is critical for the regulation of metastasis (Suen et al., 1999; Cary et al., 2002) . Taking these observations together with the fact that SFK has redundant function, it is likely that deregulation of the balance between multiple SFKs and Csk achieved by elevated expression of SFKs, downregulation of Csk or both could influence the metastatic potential of some cancer cells through primarily regulating integrin-mediated cell adhesion signaling.
We showed here that upregulation of Csk function could attenuate the metastatic potential of human colon cancer cells. Our results may provide an insight for therapy in cancer metastasis. Inhibitors of SFK, such as PP2, are known to have harmful side effects. Instead, Csk might be a more selective target for cancer therapy. Gene transfer of Csk has already been undertaken and it successfully suppressed the metastatic activity of colon cancer cells (Nakagawa et al., 2000) . Since the structure of Csk is now available (Ogawa et al., 2002) , a specific compound that binds to the SH2 domain to activate Csk may be designed; alternatively, a drug that can activate the expression of Csk may be useful.
Materials and methods

Cell culture and reagents
Colon adenocarcinoma cell lines HCC2998, HCT15 and HT29, and a gastric cancer cell line MKN22 were obtained from the Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (Tokyo, Japan). Cells were cultured in RPMI 1640 medium (Life Technologies, Inc., Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum, 2 mmol/l glutamine, 50 mg/ml penicillin and 50 mg/ml streptomycin. Cells were maintained at 371C and 5% After 48 h, cells were observed under phase-contrast microscopy. (b) HT29 cells infected with indicated adenoviruses were stained with anti-b-catenin and anti-E-cadherin antibodies followed by Cy3-conjugated and FITC-conjugated secondary antibodies, respectively. Pictures were taken at the middle surface (2 mm above the basal surface). (c) Total cell lysates from HT29 cells, treated as described above, were subjected to Western blotting using antibodies against E-cadherin, b-catenin, a-catenin and p120 CTN (left panels). For analysis of tyrosine phosphorylation of Ecadherin/b-catenin complex, the complex was immunoprecipitated with anti-E-cadherin antibody and then probed with anti-Ecadherin, anti-b-catenin or 4G10 (right panels) CO 2 in a humidified atmosphere. Cells were cultured in collagen I, laminin or poly-d-lysine-coated dishes (BD Biocoat, CA, USA) and used for experiments after reaching 80% of confluence. PP2 was purchased from Calbiochem (La Jolla, CA, USA). Stock solutions of this compound were prepared in 100% DMSO (Sigma, St Louis, MO, USA) and stored at À701C. Coating was performed with 50 mg/ml collagen I on Lab-Tech plastic chamber (Nalge Nunc International, Rochester, NY, USA) (strong coat). Ax1CAT-lacZ, Ax1CATcsk K þ and Ax1CATcsk KÀ adenovirus were obtained as described elsewhere (Takayama et al., 1999) .
Western blotting and immunoprecipitation
Cells were washed, and lysed in ODG buffer (50 mm Tris-Hcl, pH 8.0, 1 mm EDTA, 0.25 m NaCl, 20 mm NaF, 1 mm Na 3 VO 4 , 1% Nonidet P-40, 2% octyl-d-glucoside, 5 mm b-mercaptoethanol, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mm PMSF, 5% glycerol). Proteins separated by SDS-PAGE were then transferred onto a nitrocellulose membrane (Schleicher & Schuell, NH, USA). Subsequently, the membrane was treated with blocking buffer (Tris-buffered saline containing 0.1% Tween 20 (Tween-TBS)) for 2 h at room temperature. The blocked membrane was probed with primary antibodies and further incubated with a secondary antibody conjugated with horseradish peroxidase. The immunoreactivity was visualized with an enhanced chemiluminescence system (Perkin-Elmer Life Sciences, MA, USA). Primary antibodies used were antiphosphotyrosine (clone 4G10), anti-Yes, anti-FAK (clone 77), anti-E-cadherin (clone 36), anti-p120 CTN (clone 98) and anti-a catenin (clone 5) from Transduction Laboratories (KY, USA); anti-v-Src (clone Mab 327) from Calbiochem (San Diego, CA, USA); anti-Csk (clone c-20), anti-Fyn (clone FYN3), anti-Lyn (clone 44), anti-Lck (clone 2102) and antib-catenin (clone H-102) from Santa Cruz Laboratories (CA, USA); anti-Src pY418 and pY529, and FAK pY397 from Biosource Laboratories (CA, USA). Horseradish peroxidaseconjugated anti-mouse IgG (Zymed Laboratories Inc., CA, USA) and horseradish peroxidase-conjugated anti-rabbit IgG (Zymed Laboratories Inc., CA, USA) were used as secondary antibodies. For immunoprecipitation, precleared lysate (500 mg protein) was incubated with indicated antibodies and Protein G-Sepharose (Amersham Pharmacia, Buckinghamshire, UK) for 2 h at 41C. The immunoprecipitate was washed with ODG buffer and analysed by Western blotting.
Cell motility and invasion assay HT29 cells infected with adenovirus for 24 h were replated on 35 mm glass-bottom microwell dishes (IWAKI) coated with 50 mg/ml collagen I. Cell movements were monitored using Olympus IX71 microscope for 24 h. Images were collected with Cool SNAP HQ CCD camera (Roper) at 6 min intervals, digitized and stored as image stacks using MetaMorph 5.0 software (Universal Imaging). Movements of individual cells were analysed using Move-tr/2D software (Library, Tokyo). For in vitro invasion assay, cells (1.0 Â 10 5 ) were seeded into matrigel invasion chambers (BD Biocoat, CA, USA) in serumfree RPMI media (500 ml), with full RPMI media (700 ml) in the well below. Cells were allowed to grow for 48 h, after which the layer of cells in the chamber was carefully scraped off and cells adhering to the membrane beneath the chambers were stained with crystal violet and counted.
Immunofluorescence staining and confocal microscopy HT29 cells were infected with adenovirus carrying lacZ (control), Csk K þ or Csk KÀ on collagen-coated glass coverslips for 2 days. After fixation with 3.7% formaldehyde in PBS for 10 min, cells were incubated with anti-E cadherin, anti-b-catenin, anti-vinculin or antiphosphotyrosine (4G10) antibody in Tris-buffered saline containing 0.1% Tween 20; and further incubated with fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG antibody (Amersham Pharmacia Biotech, Buckinghamshire, UK) or Cy3-conjugated anti-rabbit IgG antibody (Chemichon, CA, USA). Rhodamine-phalloidin (Eugene, OR, USA) was used to stain F-actin. The stained cells were observed by immunofluorescence microscopy and/or confocal microscopy using an LSM510 (Zeiss, Germany). For inhibition assay of cell-cell contacts, HT29 cells were infected with adenovirus carrying Csk K þ in the presence of indicated concentrations of anti-human E-cadherin antibody (SHE78-7, TAKARA, Japan) for 48 h.
